Healthcare - Biotechnology - NASDAQ - US
$ 0.4612
-9.85 %
$ 18.5 M
Market Cap
-0.5
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
18.92%
Net Income
Estimate
4.98%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Cognition Therapeutics, Inc.
CGTX has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart CGTX
EBIT FORECAST
EBIT Forecast Chart CGTX
NET INCOME FORECAST
Net Income Chart CGTX